Education
About Us
Working with TipRanks
Follow Us
4DMedical Ltd (AU:4DX)
ASX:4DX
Total Valuation
4DMedical Ltd has a market cap or net worth of AU$130.66M. The enterprise value is ―.
Market CapAU$130.66M
Enterprise Value―
Share Statistics
4DMedical Ltd has 450,550,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding450,550,570
Owned by Insiders0.79%
Owned by Institutions―
Financial Efficiency
4DMedical Ltd’s return on equity (ROE) is -0.51 and return on invested capital (ROIC) is -28.27%.
Return on Equity (ROE)-0.51
Return on Assets (ROA)-0.30
Return on Invested Capital (ROIC)-28.27%
Return on Capital Employed (ROCE)-0.28
Revenue Per Employee25.89K
Profits Per Employee-248.13K
Employee Count145
Asset Turnover0.03
Inventory Turnover0.24
Valuation Ratios
The current PE Ratio of 4DMedical Ltd is -4.95. 4DMedical Ltd’s PEG ratio is -0.37.
PE Ratio-4.95
PS Ratio0.00
PB Ratio2.94
Price to Fair Value2.51
Price to FCF-4.23
Price to Operating Cash Flow-5.82
PEG Ratio-0.37
Income Statement
In the last 12 months, 4DMedical Ltd had revenue of 3.75M and earned -35.98M in profits. Earnings per share was -0.11.
Revenue3.75M
Gross Profit3.52M
Operating Income-27.97M
Pretax Income-35.93M
Net Income-35.98M
EBITDA-31.86M
Earnings Per Share (EPS)-0.11
Cash Flow
In the last 12 months, operating cash flow was -30.28M and capital expenditures -96.03K, giving a free cash flow of -30.37M billion.
Operating Cash Flow-30.28M
Free Cash Flow-30.37M
Free Cash Flow per Share-0.07
Dividends & Yields
4DMedical Ltd pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.19
52-Week Price Change-53.23%
50-Day Moving Average0.32
200-Day Moving Average0.45
Relative Strength Index (RSI)47.28
Average Volume (3m)933.05K
Important Dates
4DMedical Ltd upcoming earnings date is Aug 28, 2025, TBA Not Confirmed.
Last Earnings DateFeb 27, 2025
Next Earnings DateAug 28, 2025
Ex-Dividend Date―
Financial Position
4DMedical Ltd as a current ratio of 1.78, with Debt / Equity ratio of 8.05%
Current Ratio1.78
Quick Ratio1.74
Debt to Market Cap0.00
Net Debt to EBITDA0.80
Interest Coverage Ratio-105.95
Taxes
In the past 12 months, 4DMedical Ltd has paid 48.41K in taxes.
Income Tax48.41K
Effective Tax Rate>-0.01
Enterprise Valuation
4DMedical Ltd EV to EBITDA ratio is -4.80, with an EV/FCF ratio of -4.90.
EV to Sales40.69
EV to EBITDA-4.80
EV to Free Cash Flow-4.90
EV to Operating Cash Flow-4.95
Balance Sheet
4DMedical Ltd has AU$15.95M in cash and marketable securities with AU$4.82M in debt, giving a net cash position of -AU$11.13M billion.
Cash & Marketable SecuritiesAU$15.95M
Total DebtAU$4.82M
Net Cash-AU$11.13M
Net Cash Per Share-AU$0.02
Tangible Book Value Per Share>-AU$0.01
Margins
Gross margin is 93.60%, with operating margin of -744.92%, and net profit margin of -958.34%.
Gross Margin93.60%
Operating Margin-744.92%
Pretax Margin-957.05%
Net Profit Margin-958.34%
EBITDA Margin-848.55%
EBIT Margin-956.82%
Analyst Forecast
The average price target for 4DMedical Ltd is AU$0.76, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetAU$0.76
Price Target Upside162.07% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast471.29%
EPS Growth Forecast-4.58%